Choosing the right wild type: Behavioral and neurochemical differences between 2 populations of Sprague-Dawley rats from the same source but maintained at different sites

Journal of the American Association for Laboratory Animal Science

Volumn 46, Issue 5, 2007, Pages 13-20

  Rex, André ^a   Kolbasenko, Alexey ^a   Bert, Bettina ^a   Fink, Heidrun ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN REGION; BREEDING; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GENETIC MANIPULATION; INNERVATION; MALE; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; PHYSICAL DEVELOPMENT; RAT; SEROTONIN BRAIN LEVEL; STRAIN DIFFERENCE; ANIMAL; BRAIN LEVEL; COMPARATIVE STUDY; DRINKING; EATING; GENETICS; METABOLISM; OUTBRED STRAIN; PHYSIOLOGY; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANIMALS, OUTBRED STRAINS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN CHEMISTRY; DRINKING; EATING; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SPECIES SPECIFICITY;

EID: 36048943273     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Archer J. 1973. Tests for emotionality in rats and mice: a review. Anim Behav 21:205-235.
2. Bailey DW. 1977. Genetic drift: the problem and its possible solution by frozen-embryo storage. Ciba Found Study Group 52:291-303.
3. Belzung C, Griebel G. 2001. Measuring normal and pathological anxiety-like behavior in mice: a review. Behav Brain Res 125:141-149.
4. Belzung C, Misslin R, Vogel E, Dodd RH, Chapouthier G. 1987. Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation. Pharmacol Biochem Behav 28:29-33.
5. Bert B, Fink H, Sohr R, Rex A. 2001. Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety. Pharmacol Biochem Behav 70:411-420.
6. Blizard DA, Wada Y, Onuki Y, Kato K, Mori T, Taniuchi T, Hosokawa H, Otobe T, Takahashi A, Shisa H, Hiai H, Makino J. 2005. Use of a standard strain for external calibration in behavioral phenotyping. Behav Genet 35:323-332.
7. Boissier JR, Simon P. 1962. The exploration reaction in the mouse. Preliminary note. Therapie 17:1225-1232.
8. Chia R, Achilli F, Festing MF, Fisher EM. 2005. The origins and uses of mouse outbred stocks. Nat Genet 37:1181-1186.
9. Claassen V. 1994. Neglected factors in pharmacology and neuroscience research. Amsterdam: Elsevier.
10. Crawley JN. 2000. What's wrong with my mouse: behavioral phenotyping of transgenic and knockout mice. New York: Wiley-Liss.
11. de Jerphanion A. 2007. Use of Sprague-Dawley rats from Janvier as wild-type controls.
12. Dunham NW, Miya TS. 1957. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46:208-209.
13. Eggenberger E. 1973. Model populations for assessment of rotation systems in experimental animal breeding. Z Versuchstierkd 15:297-331.
14. Eiben R, Bomhard EM. 1999. Trends in mortality, body weights and tumor incidences of Wistar rats over 20 years. Exp Toxicol Pathol 51:523-536.
15. Falconer DS. 1981. Introduction to quantitative genetics. London: Longmans.
16. Festing MF. 1999. Warning: the use of heterogenous mice may seriously damage your research. Neurobiol Aging 20:237-244; discussion 245-236.
17. Festing MF [Internet]. 2006. Isogenic information [cited 18 May 2007]. Available from http://www.isogenic.info/index.html.
18. File SE. 1981. Effects of a piperazine derivative, piribedil, on exploration, locomotor activity and social behavior in the rat. Prog Neuropsychopharmacol 5:245-255.
19. File SE. 1996. Recent developments in anxiety, stress, and depression. Pharmacol Biochem Behav 54:3-12.
20. File SE, Wardill AG. 1975. The reliability of the hole-board apparatus. Psychopharmacologia 44:47-51.
21. Geller J. 2007. Personal communication.
22. Green E. 1981. Genetics and probability in animal breeding experiments. New York: Oxford University Press.
23. Griebel G. 1995. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395.
24. Griebel G, Belzung C, Misslin R, Vogel E. 1993. The free-exploratory paradigm: an effective method for measuring neophobic behavior in mice and testing potential neophobia-reducing drugs. Behav Pharmacol 4:637-644.
25. Griebel G, Saffroy-Spittler M, Misslin R, Vogel E, Martin JR. 1990. Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behavior in mice. Psychopharmacology 102:498-502.
26. Hall CS. 1934. Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. J Comp Physiol Psychol 18:385-403.
27. Handley SL, Mithani S. 1984. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behavior. Naunyn-Schmiedeberg Arch Pharmacol 327:1-5.
28. Hedrich HJ, Rapp KG, Zschege C. 1975. Genetic constancy, respectively subline drifting of inbred strains of rats and mice. Z Versuchstierkd 17:263-274.
29. Hogg S. 1996. A review of the validity and variability of the elevated-plus maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21-30.
30. Jarvik ME, Kopp R. 1967. An improved one-trial passive avoidance learning situation. Psychol Rep 21:221-224.
31. Johnston AL, File SE. 1986. 5-HT and anxiety: promises and pitfalls. Pharmacol Biochem Behav 24:1467-1470.
32. Jones BJ, Roberts DJ. 1968. A rotarod suitable for quantitative measurements of motor incoordination in naive mice. Naunyn-Schmiedeberg Arch Pharmacol 259:211.
33. Kudryavtseva N. 2007. Personal communication.
34. Mayr E. 1954. Change of genetic environment and evolution. In: Huxley J, editor. Evolution as a process. London: Illen and Unwin. p 157-180.
35. Mayr E. 1963. Animal species and evolution. Cambridge (UK): Belknap Press.
36. Montgomery KC, Monkman JA. 1955. The relation between fear and exploratory behavior. J Comp Physiol Psychol 48:132-136.
37. Mullins JJ, Peters J, Ganten D. 1990. Fulminant hypertension in transgenic rats harboring the mouse ren-2 gene. Nature 344:541-544.
38. Nagasaki H, Yokoi H, Arima H, Hirabayashi M, Ishizaki S, Tachikawa K, Murase T, Miura Y, Oiso Y. 2002. Overexpression of vasopressin in the rat transgenic for the metallothionein-vasopressin fusion gene. J Endocrinol 173:35-44.
39. Nelson DL, Gehlert DR. 2006. Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29:49-60.
40. Oiso Y, Nagasaki H, Yokoi H. 2003. Transgenic rat models of vasopressin overexpression. Nagoya J Med Sci 66:87-93.
41. Ou LC, Chen J, Fiore E, Leiter JC, Brinck-Johnsen T, Birchard GF, Clemons G, Smith RP. 1992. Ventilatory and hematopoietic responses to chronic hypoxia in two rat strains. J Appl Physiol 72:2354-2363.
42. Papaioannou VE, Festing MF. 1980. Genetic drift in a stock of laboratory mice. Lab Anim 14:11-13.
43. Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates. London: Academic Press.
44. Pellow S. 1986. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Meth Find Exp Clin Pharmacol 8:557-565.
45. Pellow S, Chopin P, File SE, Briley M. 1985. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167.
46. Prut L, Belzung C. 2003. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33.
47. Rex A, Marsden CA, Fink H. 1993. Effect of diazepam on cortical 5-HT release and behavior in the guinea pig on exposure to the elevated-plus maze. Psychopharmacology 110:490-496.
48. Rex A, Marsden CA, Fink H. 1993. Validation of the elevated plus maze using dopaminergic drugs. Naunyn-Schmiedeberg Arch Pharmacol 347(Suppl):130.
49. Rex A, Sondern U, Voigt JP, Franck S, Fink H. 1996. Strain differences in fear-motivated behavior of rats. Pharmacol Biochem Behav 54:107-111.
50. Rex A, Voigt JP, Fink H. 2005. Anxiety but not arousal increases 5-hydroxytryptamine release in the rat ventral hippocampus in vivo. Eur J Neurosci 22:1185-1189.
51. Rex A, Voigt JP, Gustedt C, Beckett S, Fink H. 2004. Anxiolytic-like profile in Wistar, but not Sprague-Dawley, rats in the social interaction test. Psychopharmacology 177:23-34.
52. Rex A, Voigt JP, Voits M, Fink H. 1998. Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs. Pharmacol Biochem Behav 59:677-683.
53. Robertson A. 1967. The nature of quantitative variation. In: Brink A, editor. Heritage from Mendel. Madison: The University of Wisconsin. p 265-280.
54. Rodgers RJ, Cole JC. 1995. The elevated-plus maze: pharmacology, methodology, and ethology. In: Cooper SJ, Hendrie CA, editors. Ethology and psychopharmacology. London: John Wiley and Sons. p 9-44.
55. Sander M, Ganten D, Mellon SH. 1994. Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin. Proc Natl Acad Sci U S A 91:148-152.
56. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M. 1999. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A 96:3975-3980.
57. Schwarting RK, Pawlak CP. 2004. Behavioral neuroscience in the rat: taking the individual into account. Meth Find Exp Clin Pharmacol 26:17-22.
58. Schwarting RK, Thiel CM, Muller CP, Huston JP. 1998. Relationship between anxiety and serotonin in the ventral striatum. Neuroreport 9:1025-1029.
59. Sluka KA, Westlund KN. 1992. Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat. Brain Res 579:67-73.
60. Spielberger CD, O'Neil HF Jr, Hansen DN. 1972. Anxiety, drive theory, and computer-assisted learning. Prog Exp Pers Res 6:109-148.
61. Spruijt BM, van Hooff JA, Gispen WH. 1992. Ethology and neurobiology of grooming behavior. Physiol Rev 72:825-852.
62. Suzuki DT, Griffiths AJF, Miller JH, Lewontin RC. 1989. Chromosome mutation II: changes in number. In: Suzuki DT, Griffiths AJF, editors. An introduction to genetic analysis. New York: WH Freeman and Company. p 198-214
63. Tennekes H, Kaufmann W, Dammann M, van Ravenzwaay B. 2004. The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment. Regul Toxicol Pharmacol 40:293-304.
64. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ. 1994. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension 23:422-427.
65. van der Poel AM. 1967. Ethological study of the behavior of the albino rat in a passive-avoidance test. A Physiol Pharmacol Neerl 14:503-505.
66. Voigt JP, Hortnagl H, Rex A, van Hove L, Bader M, Fink H. 2005. Brain angiotensin and anxiety-related behavior: the transgenic rat TGR(ASrAOGEN)680. Brain Res 1046:145-156.
67. Walsh RN, Cummins RA. 1976. The open-field test: a critical review. Psychol Bull 83:482-504.
68. Wilson W, Voigt P, Bader M, Marsden CA, Fink H. 1996. Behavior of the transgenic (mREN2)27 rat. Brain Res 729:1-9.
69. Wise CD, Berger BD, Stein L. 1973. Evidence of noradrenergic reward receptors and serotonergic punishment receptors in the rat brain. Biol Psych 6:3-21.
70. Wongwitdecha N, Marsden CA. 1996. Social isolation increases aggressive behavior and alters the effects of diazepam in the rat social interaction test. Behav Brain Res 75:27-32.
71. Wright IK, Upton N, Marsden CA. 1991. Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiol Behav 50:1129-1132.
72. Yoon YW, Lee DH, Lee BH, Chung K, Chung JM. 1999. Different strains and substrains of rats show different levels of neuropathic pain behaviors. Exp Brain Res 129:167-171.